RF-211-UB-Lyn
(Plasmid
#79184)
-
PurposeExpression of the C-terminal fragment of Lyn kinase that is endogenously generated by caspase cleavage in mammalian cells
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 79184 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA 3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5600
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameLyn
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1800
-
Mutationdelta 1-18
-
Entrez GeneLYN (a.k.a. JTK8, SAIDV, p53Lyn, p56Lyn)
- Promoter CMV
-
Tags
/ Fusion Proteins
- ubiquitin (N terminal on backbone)
- 3x Flag (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
RF-211-UB-Lyn was a gift from Richard Fahlman (Addgene plasmid # 79184 ; http://n2t.net/addgene:79184 ; RRID:Addgene_79184) -
For your References section:
The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway. Eldeeb MA, Fahlman RP. Oncotarget. 2014 May 15;5(9):2714-22. 10.18632/oncotarget.1931 PubMed 24798867